Amantadine Hydrochloride Solution
Product Images NDC 61037-484

This is a prescription medication containing Amantadine Hydrochloride in oral solution form with a concentration of 50 mg per 5 mL. It is intended for oral use only and should be kept at room temperature. The medication should be dispensed in a tightly closed container to protect it from moisture. It is essential to store the medication out of reach of children. The package contains 16 fluid ounces (473 mL) of the solution. Detailed prescribing information is enclosed in the leaflet attached to the label.*

Amantadine Hydrochloride Oral Solution USP is a medication indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. It also serves as a treatment for Parkinson's disease and drug-induced extrapyramidal reactions. The text provides detailed information on the pharmacodynamics and pharmacokinetics of amantadine hydrochloride, including mechanisms of action, clinical pharmacology, drug resistance, and indications for use. It discusses the drug's effectiveness in preventing pneumonia or other complications related to influenza A virus infection, as well as its role in treating respiratory tract illnesses. Additionally, it highlights considerations before initiating treatment with amantadine hydrochloride, such as the importance of annual vaccination and monitoring for emergence of resistance mutations.*

This text provides a comprehensive overview of the warnings, precautions, and information related to the medication Amantadine hydrochloride. It covers a range of topics such as potential side effects, risks associated with certain medical conditions, overdose symptoms, and the importance of careful dosage adjustment in patients with specific health conditions like renal impairment. The text also discusses the risks of abrupt discontinuation of the medication, potential interactions with other drugs, and specific considerations for patients with Parkinson's disease. Moreover, it highlights the need for close monitoring for serious conditions like Neuroleptic Malignant Syndrome and melanoma in patients using Amantadine hydrochloride. While emphasizing the importance of patient education and seeking medical attention when needed, the text also addresses potential drug interactions, carcinogenic and mutagenic potentials, and guidelines on concurrent use with influenza vaccines.*

This text provides detailed information on the dosage and administration of Amantadine Hydrochloride, a medication used to treat certain conditions like extrapyramidal reactions and impaired renal function. It describes the recommended dosages for different patient scenarios, such as those not responding to other medications or experiencing side effects from levodopa. The text also mentions potential benefits of combining Amantadine Hydrochloride with other anti-parkinson drugs for enhanced therapeutic effects. Additionally, it includes instructions on how to store the medication and references related to its use.*